No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

The technology – called Antibody Transport Vehicle (ATV): Amyloid ... experimental drug for Parkinson’s disease driven by a the LRRK2 mutation, which has advanced into phase 3 testing.